PharmaCyte Biotech Inc (PMCB)

[n3m3sis]

Agreed!

I thought something like this was in the works.
Hence the word "Landmark"

FDA seem sure enough of PMCB to want to skip Phase 3 and go straight to market. Subject of course, to even more favorable results.

The thing is, I feel sorry for the patients who will be on the other side of the trial, not getting ciab.

IMPORTANT. The trials may be halted at 50% if efficacy is proved.

GO GO $PMCB